Intensive glucose control for acute myocardial infarction: An unresolved clinical conundrum

JAMA Internal Medicine

Volumn 174, Issue 5, 2014, Pages 825-826

  Sardar, Partha ^a   Nairooz, Ramez ^a   Chatterjee, Saurav ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACUTE HEART INFARCTION; BLOOD GLUCOSE MONITORING; GLYCEMIC CONTROL; HEART MUSCLE PERFUSION; HUMAN; INSULIN TREATMENT; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACUTE CORONARY SYNDROME; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MYOCARDIAL INFARCTION;

EID: 84899838723     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.374     Document Type: Letter

References (3)

1. de Mulder M, Umans VA, Cornel JH, et al. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial. JAMA Intern Med. 2013;173(20):1896-1904.
2. Chatterjee S, Sharma A, Lichstein E, Mukherjee D. Intensive glucose control in diabetics with an acutemyocardial infarction does not improve mortality and increases risk of hypoglycemia-ameta-regression analysis. Curr Vasc Pharmacol. 2013;11(1):100-104.
3. Malmberg K, Rydén L,Wedel H, et al; DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acutemyocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26(7):650-661.